Hims & Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.
Opinion
As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study
As a scientist, I am disgusted. As an NFL widow who witnessed unimaginable suffering, I am furious,” writes Eleanor M. Perfetto.
FDA will take “decisive steps” to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs ...
WASHINGTON — President Trump said his administration’s new TrumpRx website will offer the cheapest prices in the world for 43 ...
The Trump administration is moving forward with a personnel rule that critics say will subject a broader swath of the federal workforce to political pressure ...
ARPA-H, the “moonshot” biomedical agency established under the Biden administration, laid off staff last week, according to ...
China criticized the United States for withdrawing from the WHO, saying countries should not place domestic politics ahead of ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
President Trump on Thursday night launched TrumpRx, the website he and his aides have touted as a platform aimed at lowering drug prices ...
Roivant and its spinout Priovant said this morning that their immune-modifying drug significantly outperformed placebo in ...
The Environmental Working Group, an advocacy group, slammed the announcement as a “retreat” from health secretary Kennedy’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results